Zymeworks

ZYME

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing prote …

Insider trades and stock quote 2023-2025

All insider trades at Zymeworks

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
1/17/2025 BuyEcor1 Capital, LLC Director $13.9 $273,998
1/16/2025 BuyEcor1 Capital, LLC Director $13.9 $1,689,541
1/15/2025 BuyEcor1 Capital, LLC Director $14.0 $546,671
1/14/2025 BuyEcor1 Capital, LLC Director $13.6 $739,265
1/13/2025 BuyEcor1 Capital, LLC Director $13.4 $992,875
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)